None listed
Conditions
Interventions
Intervention1: Tablet Letrozole 25mg: Tablet Letrozole 25mg Given On Day 3 Of Menstrual Cycle
Control Intervention1: Tablet Letrozole 5mg: Tablet Letrozole 5mg From Day 3 To Day 7 Daily for 5 Days
Sponsors
Datta Meghe Institute Of Higher Education and Research
Eligibility
Inclusion criteria
Inclusion criteria: Women between 18 to 40years age with at least 18 months of infertility, documented tubal patency, confirmed ovulation, normal partner semen parameters and no ovulation induction treatment in the preceding 6 months were included in the study.
Exclusion criteria
Exclusion criteria: Women with endometriosis, congenital anomalies of the female genital tract, renal or hepatic disease, known hypersensitivity to letrozole or a history of fractures were excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ovulation will be considered successful when confirmed by documented evidence of a follicle of at least 18mm in size that is likely to ovulateTimepoint: After 6 to 7 days from the last dose of the drug | — |
Secondary
| Measure | Time frame |
|---|---|
| Positive serum beta human chorionic GND of value more than 25mIU per mlTimepoint: On day 28 of the cycle | — |
Countries
India
Contacts
Public ContactDr Meena Jotwani
Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research
Outcome results
None listed